RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Health Sciences - Stock

Health Sciences Stocks 2024

Health Sciences Stocks

35,860

Ticker

IWKS

ISIN

US0010582056

In 2024, Health Sciences had 35,860 outstanding stocks, a 31.5% change from the 27,270 stocks in the previous year.

The Health Sciences Stocks history

YEARNUMBER OF STOCKS (undefined USD)
200835.86
200727.27
200621.03
200519.77
200419.26
200318.54
200220
200120
200020
199920
199820
199710
199620
199510
199410
199310
199210
199110
199010
198910

Health Sciences shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Health Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Health Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Health Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Health Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Health Sciences Aktienanalyse

What does Health Sciences do?

The Health Sciences Corp is a company that has been active in the biotechnology industry since 1997. It was founded with the goal of developing practical and innovative solutions for medical problems. The company is based in Toronto, Canada, and operates worldwide. The business model of the Health Sciences Corp includes several divisions, all focused on the field of biotechnology. The main divisions are the development of diagnostic tests, drug development, and the production of medical devices. In the field of diagnostic tests, the Health Sciences Corp offers various products that are intended to contribute to faster and more accurate disease diagnosis. An example of this is the reliable blood glucose test, which is particularly used in the diagnosis of diabetes and other metabolic diseases. The company also offers tests for the detection of infectious diseases such as HIV or hepatitis. In the area of drug development, the Health Sciences Corp focuses on developing innovative solutions for particularly difficult-to-treat diseases. These include cancer, autoimmune, and neurodegenerative diseases. Both completely new active substances and novel combinations of existing therapies are developed for this purpose. In addition to drug development, the company also works on the production of medical products. This includes implants as well as devices for monitoring vital parameters. An example of this is the wireless sensor for monitoring heart rhythm disorders, which is applied to the patient's skin and transfers data to the doctor's mobile phone. Over the years, the Health Sciences Corp has received numerous awards and prizes for technological innovations as well as medical research. The company makes a particularly significant contribution to cancer research. It works closely with renowned research institutions and universities, thus constantly contributing to new findings. The knowledge gained in the process also flows into the development of new therapies. In 2016, the Health Sciences Corp founded a subsidiary called MaRS Innovation, which aims to commercialize technology from Canadian universities. The goal is to transform new technologies that have been researched in universities into commercial products and services. The vision of the Health Sciences Corp is to contribute to sustainably improving healthcare for people worldwide through innovative therapies and medications. In addition, the company places great importance on adhering to ethical and moral standards and behaving respectfully towards the environment and society. Overall, the company has an excellent reputation in the biotechnology industry and is considered a pioneer in the development of practical and innovative solutions for medical problems. Health Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Health Sciences's Shares Outstanding

Health Sciences's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Health Sciences’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Health Sciences’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Health Sciences’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Health Sciences Stock

How many stocks are there of Health Sciences?

The current number of stocks of Health Sciences is 35,860 undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Health Sciences are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Health Sciences evolved in recent years?

The number of shares of Health Sciences has increased by 31.5% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Health Sciences as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Health Sciences?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Health Sciences pay?

Over the past 12 months, Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Health Sciences?

The current dividend yield of Health Sciences is .

When does Health Sciences pay dividends?

Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Health Sciences?

Health Sciences paid dividends every year for the past 0 years.

What is the dividend of Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Health Sciences located?

Health Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Health Sciences from 7/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Health Sciences pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of Health Sciences in the year 2023?

In the year 2023, Health Sciences distributed 0 USD as dividends.

In which currency does Health Sciences pay out the dividend?

The dividends of Health Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Health Sciences

Our stock analysis for Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.